Glycopeptides

mucin 1, cell surface associated ; Homo sapiens







58 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35544340 Integrated Chemoenzymatic Approach to Streamline the Assembly of Complex Glycopeptides in the Liquid Phase. 2022 May 25 1
2 33469292 The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines. 2021 1
3 33560106 Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin. 2021 Feb 23 2
4 33645601 Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate. 2021 Mar 21 1
5 31729101 Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope. 2020 Jan 1
6 32672464 Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics. 2020 Aug 13 3
7 33001366 TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution. 2020 Dec 1
8 33010570 Synthesis of MUC1-derived glycopeptide bearing a novel triazole STn analog. 2020 Dec 1
9 30504228 Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands. 2019 Jan 25 1
10 31498587 Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles. 2019 Oct 18 2
11 31588183 Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. 2019 1
12 28440596 Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating Adjuvant. 2017 May 22 1
13 28675699 Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice. 2017 Sep 7 1
14 29022615 Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides. 2017 Nov 27 1
15 29166012 The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer. 2017 Dec 20 1
16 27340743 Convergent Solid-Phase Synthesis of Macromolecular MUC1 Models Truly Mimicking Serum Glycoprotein Biomarkers of Interstitial Lung Diseases. 2016 Jul 13 2
17 26129647 Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides. 2015 Jul 28 1
18 24246952 A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides. 2014 Mar 3
19 25303614 Fast epitope mapping for the anti-MUC1 monoclonal antibody by combining a one-bead-one-glycopeptide library and a microarray platform. 2014 Nov 24 2
20 23259747 Site-specific conformational alteration induced by sialylation of MUC1 tandem repeating glycopeptides at an epitope region for the anti-KL-6 monoclonal antibody. 2013 Jan 15 2
21 23535562 One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid. 2013 Aug 15 5
22 23616304 Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid. 2013 Jun 3 1
23 23652307 Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. 2013 May 28 1
24 23732560 Convergent synthesis of MUC1 glycopeptides via serine ligation. 2013 Jul 14 2
25 24160308 Stereoselective synthesis of sialylated tumor-associated glycosylamino acids. 2013 Nov 15 1
26 21880669 Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. 2012 Feb 2
27 21344374 Seromic profiling of colorectal cancer patients with novel glycopeptide microarray. 2011 Apr 15 1
28 21451866 Rational design of a Tn antigen mimic. 2011 May 14 1
29 21538615 Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry. 2011 May 27 2
30 21768105 Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity. 2011 Sep 16 1
31 20563275 Synthesis of glycosylated β³-homo-threonine conjugates for mucin-like glycopeptide antigen analogues. 2010 May 12 2
32 20574591 Chemoenzymatic synthesis of glycosylphosphatidylinositol-anchored glycopeptides. 2010 Aug 21 1
33 20726594 A high-throughput O-glycopeptide discovery platform for seromic profiling. 2010 Oct 1 1
34 20878823 Synthetic antitumor vaccines from tetanus toxoid conjugates of MUC1 glycopeptides with the Thomsen-Friedenreich antigen and a fluorine-substituted analogue. 2010 Nov 2 1
35 19007994 Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes. 2009 Nov 2
36 19236026 Efficient substitution reaction from cysteine to the serine residue of glycosylated polypeptide: repetitive peptide segment ligation strategy and the synthesis of glycosylated tetracontapeptide having acid labile sialyl-T(N) antigens. 2009 Mar 20 1
37 19852465 Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains. 2009 Nov 24 1
38 19899793 An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. 2009 Dec 2 6
39 17804752 Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. 2007 Sep 1 2
40 16207894 Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance. 2006 Feb 3
41 16467946 Formation of lactones from sialylated MUC1 glycopeptides. 2006 Feb 21 1
42 16642533 Synthesis and structural model of an alpha(2,6)-sialyl-t glycosylated MUC1 eicosapeptide under physiological conditions. 2006 Jun 23 1
43 15814824 Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses. 2005 Aug 1
44 16042579 Design of a MUC1-based cancer vaccine. 2005 Aug 1
45 16104759 Combinatorial synthesis of MUC1 glycopeptides: polymer blotting facilitates chemical and enzymatic synthesis of highly complicated mucin glycopeptides. 2005 Aug 24 3
46 14991920 Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines. 2004 1
47 14993254 Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas. 2004 Mar 1 1
48 12778480 MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue. 2003 Jun 1
49 12925576 Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core. 2003 Dec 1
50 14552419 Synthetic glycopeptides for the development of tumour-selective vaccines. 2003 Sep 1